
معرفی
Benoît Guery is an Associate Professor at the Faculty of Biology and Medicine (FBM) of the University of Lausanne (UNIL) and serves as Chief Physician in the Infectious Diseases Department at the Lausanne University Hospital (CHUV), a position he has held since September 1, 2016. His dual academic and clinical roles place him at the forefront of infectious disease research and patient care in Switzerland.
His research is primarily focused on Clostridioides difficile infections (CDI) and the human microbiota, with a strong emphasis on epidemiology, pathogenesis, and innovative therapies such as fecal microbiota transplantation (FMT). He leads a major investigator-initiated clinical trial funded by the Swiss National Science Foundation, comparing conventional and FMT-based treatments for recurrent CDI across nine Swiss centers. This work is supported by the CHUV’s Swissmedic-accredited FMT center, the only one in Switzerland. His research extends into the broader field of host-microbiota interactions as a principal investigator in Work Package 1 of the NCCR 'Microbiomes', a large interdisciplinary initiative involving UNIL, ETH Zurich, EPFL, and other Swiss universities.
Guery also coordinates a phage therapy development program at CHUV in collaboration with clinical and research teams, contributing to the understanding of the pulmonary microbiota. His scientific contributions include over 200 publications in high-impact journals such as The Lancet, British Medical Journal, and PLoS One, as well as participation in the development of European guidelines for CDI management. He has served on the program implementation committee of the European Congress of Clinical Microbiology and Infectious Diseases (2019–2022) and is an active member of several learned societies.
- Principal Investigator, NCCR 'Microbiomes', Work Package 1
- Lead, Swiss National Science Foundation-funded IICT on CDI and FMT
- Coordinator, CHUV Phage Therapy Development Program
- Member, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
He has supervised numerous master’s and doctoral students and is deeply engaged in pre- and post-graduate medical education in both Switzerland and France. His work bridges clinical practice, translational research, and academic leadership, making him a central figure in the field of infectious diseases in Europe.





